Quentin Perrier
Quentin Perrier is a member of the research team at Wake Forest University, focusing on the innovative use of 3D printing to create viable human pancreatic islets for diabetes treatment. His contributions to the study, presented at the ESOT Congress 2025, highlight the potential of bioprinted islets to function effectively for extended periods, marking a significant advancement in regenerative medicine aimed at improving the quality of life for diabetes patients.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Quentin Perrier is a member of the research group who explained the innovative bioink used in the study.
8